Q-Line Biotech IPO Details
The Q-Line Biotech IPO is a book build issue with a total issue size of ₹214 cr, comprising of fresh issue of 6253200 equity shares. Q-Line Biotech IPO opened for subscription on May 21, 2026 and closed on May 25, 2026. Q-Line Biotech IPO is set price band at ₹326 to ₹343 per share, with a lot size of 400 shares. Minimum investment for Retail investors was ₹274,400.00 (at the upper price band) to apply for one lot.
The basis of allotment got finalized on May 26, 2026, and listed on the NSE on May 29, 2026.
Purva Sharegistry India Pvt Ltd has been appointed as the registrar. Hem Securities Limited and Share India Capital Services Private Limited are the Book Running Lead Manager for the issue.
Before investing in the Q-Line Biotech IPO, investors should review the company's financial performance, business objectives, and risk factors mentioned in the offer documents and apply before the subscription window closes.
- Price Band
- ₹ 326 – 343
- Lot Size
- 400
- Issue Size
- ₹214 Cr
- Minimum Investment
- ₹274400 (800 Shares)
- Listing Date
- 29 May 2026
Current GMP
₹112 (+32.65%)
*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.
About Q-Line Biotech Limited
Q-Line Biotech IPO Promoters
- Saurabh Garg
- Amita Garg
- Ayush Garg
- Ajay Kumar Mahanty
- Abhay Agrawal
Promoters Holding
Holding Pre Issue
96.77%
Holding Post Issue
67.51%
Q-Line Biotech IPO Objective
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects.
- To meet Working Capital requirements
- Repayment of certain borrowing availed by our Company, in part or full
- General Corporate Purpose
Address / Contact Info
Q-Line Biotech Limited
298-281, Transport Nagar,
Kanpur Road Adjacent Transport Nagar Metro Station
Lucknow, Uttar Pradesh, 226012
Email:compliance@qlinebiotech.com
Telephone: +91 522-2435570
Website:https://qlinebiotech.com/
IPO Snapshot
Book Running Lead Managers
- Hem Securities Limited
- Share India Capital Services Private Limited
Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.
Frequently Asked Questions
Everything you need to know before applying to an IPO.
Q-Line Biotech IPO is a Book-building IPO with a total issue size of ₹214 crore. The Q-Line Biotech IPO price band is ₹326 to 343 per share. The Q-Line Biotech IPO subscription opens on Thu, May 21, 2026, and closes on Mon, May 25, 2026. The Q-Line Biotech IPO will be listed on the NSE. Purva Sharegistry India Pvt Ltd is the registrar for the Q-Line Biotech IPO.
The Q-Line Biotech IPO opens on Thu, May 21, 2026 and closes on Mon, May 25, 2026
Q-Line Biotech IPO Price Band is ₹326 to 343 per share.
Q-Line Biotech IPO lot size is 400 shares, Retail investors need a minimum investment of ₹274400 based on the upper price band
The minimum investment for Q-Line Biotech IPO is ₹274400, based on one lot of 400 shares at the upper price band of ₹343 per share.
Investors can apply for the Q-Line Biotech IPO through the ASBA (Application Supported by Blocked Amount) facility offered by their bank or through UPI using a SEBI-registered broker or trading app. Select the desired lot size, enter your bid within the price band, and submit the application before Mon, May 25, 2026. The application amount remains blocked until the Q-Line Biotech IPO allotment is finalized.
Q-Line Biotech IPO issue size is ₹214 crores.
Q-Line Biotech IPO allotment date is Wed, Jul 1, 2026.
The registrar for Q-Line Biotech IPO is Purva Sharegistry India Pvt Ltd. Investors can go to Purva Sharegistry India Pvt Ltd website to check Q-Line Biotech IPO allotment status, refund processing, and other IPO-related information.
The Q-Line Biotech IPO GMP (Grey Market Premium) is ₹112 as of Fri, May 29, 2026. Based on the upper price band of ₹343 per share, the estimated Q-Line Biotech IPO listing price is ₹455, indicating a potential listing gain of approximately 0% over the issue price.